Women, Hormones and Neurodiversity: What do we know?
There is a question I hear more and more often from women with ADHD or autism:
“Why do my symptoms seem to change with my hormones?”
For some, it is the week before their period when concentration disappears, emotional regulation becomes much harder or medication suddenly feels less effective. For others, it is pregnancy, the postpartum period or perimenopause that seems to expose difficulties they had previously been able to manage.
And then there are women who only begin to wonder whether they might be neurodivergent at all when they reach midlife.
Something changes. The strategies that have worked for years stop working quite so well. The noise feels louder. Executive functioning becomes harder. Masking becomes exhausting. Work takes more effort. Someone who has spent decades thinking she is simply disorganised, oversensitive or bad at coping starts asking whether there might be another explanation.
The relationship between hormones and neurodivergence is still a relatively young area of research, and there are far more questions than answers. But the evidence has grown considerably over the past few years, particularly around ADHD, the menstrual cycle and menopause.
What is emerging is not a simple story of “female hormones making neurodivergence worse”.
It is much more interesting than that.
First, what do we mean by neurodiversity?
Neurodiversity refers to the natural variation in how human brains develop and function. The term is commonly used in relation to neurodevelopmental differences such as autism, ADHD, dyslexia, dyspraxia and dyscalculia, although people use the language in slightly different ways.
Autism, for example, is a lifelong neurodivergence and disability that influences how somebody experiences and interacts with the world. Autistic people vary enormously in their strengths, needs, communication styles and sensory experiences.
That variety is important because conversations about neurodivergence can easily drift towards two extremes. At one end, everything gets framed as deficit and disorder. At the other, neurodivergence becomes a “superpower” and the genuinely disabling parts of someone’s experience disappear from view.
Neither is particularly useful.
Some people experience aspects of their neurodivergence as strengths. Others experience substantial disability. Many experience both, depending on the environment they are in and the demands being placed on them.
The useful question is usually not whether neurodivergence is good or bad.
It is what this particular person experiences, and what helps them function well.
Why women have historically been missed
One of the reasons the hormones conversation is emerging now is that we are also getting better at recognising neurodivergence in women.
Historically, much of the research and many of the diagnostic models for both autism and ADHD were shaped around boys and men. Women whose presentation did not resemble those familiar stereotypes were easier to overlook.
An autistic woman may be socially interested, have friendships and appear outwardly confident while putting enormous effort into understanding and performing social expectations. A woman with ADHD may not have been the disruptive child in the classroom. She may instead have been daydreamy, chronically disorganised, anxious, perfectionistic or incredibly good at compensating.
Recent reviews of female ADHD continue to highlight delayed diagnosis, different patterns of executive-function difficulty and the role of sociocultural expectations in women being missed.
That matters when we talk about hormones because some women are reaching hormonal transitions before their neurodivergence has ever been recognised.
When the amount of compensation they can sustain changes, the underlying pattern may suddenly become much more visible.
ADHD is where some of the strongest hormonal evidence is emerging
Of all the areas we are discussing, ADHD currently has some of the clearest evidence of an interaction with reproductive hormones.
A 2025 systematic review of ADHD and sex hormones in females concluded that the evidence is broadly suggestive of a relationship, particularly during puberty and across the menstrual cycle, while also pointing out that the existing studies are small and quite heterogeneous.
There are plausible biological reasons for this. Oestrogen interacts with dopamine systems in the brain, and dopamine is central to many of the cognitive processes involved in ADHD.
Some women report that attention, motivation, working memory and emotional regulation become more difficult at certain points in the menstrual cycle, particularly when oestrogen is falling. A recent review of menstrual-cycle-related hormonal fluctuations in ADHD similarly described growing evidence for changes in mood and cognition across the cycle, alongside reports that stimulant medication can feel less effective for some women premenstrually.
The science is not yet strong enough to say that every woman with ADHD will experience a predictable cyclical pattern.
But the reports are common enough, and the emerging evidence consistent enough, that the question deserves to be taken seriously.
What about changing ADHD medication across the cycle?
This is an area where interest is growing very quickly.
A small 2023 case series explored increasing psychostimulant doses during the premenstrual phase in nine women with ADHD who reported significant cyclical worsening. All nine reported improvements in ADHD symptoms and mood with minimal adverse effects and chose to continue the adjusted dosing pattern.
That was interesting, but it was only nine women. So I would be very careful about turning it into a blanket recommendation.
More recent reviews continue to emphasise that female-specific ADHD treatment research is badly lacking, including research on menstrual-cycle effects and medication response.
For now, the useful message is simply that if someone notices a consistent pattern in symptoms or medication effectiveness across the menstrual cycle, that is worth discussing with the clinician managing their ADHD treatment rather than changing medication independently.
Autism and the menstrual cycle are less well understood
The evidence around autism and reproductive hormones is less developed.
A 2025 scoping review of autism, menstruation and mental health concluded that autistic people can experience significant difficulties around menstruation, including changes in mental health, sensory experiences and everyday functioning. But the research base remains small, inconsistent and methodologically limited.
This is important because there has been a tendency online to jump from lived experience to very definite biological explanations.
For example, some autistic people describe increased sensory sensitivity, emotional dysregulation, reduced capacity to mask or greater overwhelm around particular parts of the menstrual cycle. Those experiences matter.
But we do not yet know exactly why they happen.
We also need to be cautious with claims that PMDD is dramatically more common in autistic women. Older studies generated striking prevalence figures, but more recent work has produced mixed results, and the current evidence is not strong enough to give a confident autism-specific PMDD prevalence estimate.
That does not mean there is no relationship.
It means the science has not caught up with the question yet.
Hormonal health and neurodivergence may interact in both directions
One thing I think is missing from a lot of the discussion is the assumption that hormones are acting on neurodivergence.
The relationship is probably more complicated.
Imagine someone who already finds sensory input overwhelming. A period of poor sleep, pain, hot flushes or significant premenstrual mood symptoms could reduce the amount of capacity she has available to manage that sensory environment.
Or somebody with ADHD may already find planning, organisation and emotional regulation effortful. If sleep deteriorates or cognitive symptoms increase during a hormonal transition, the systems she has spent years using to compensate may suddenly become less effective.
That does not necessarily mean her autism or ADHD has become biologically “more severe”.
It may mean there is less spare capacity available to compensate for an environment that was already demanding.
That distinction feels particularly important in the workplace.
Perimenopause is becoming a major part of this conversation
This is probably where the research has moved most noticeably since the original version of this article.
Autistic people have been increasingly involved in research about menopause, and their accounts suggest that the transition can be especially difficult for some.
A 2024 qualitative study involving autistic participants described experiences of increased sensory sensitivity, difficulties with emotional regulation and executive functioning, changing capacity for masking and major effects on everyday life. The researchers described menopause as a “perfect storm” for some participants.
A subsequent mixed-methods systematic review also found that menopausal symptoms could substantially affect autistic people’s work, relationships and sense of autistic identity. The quantitative evidence was limited, but pointed towards greater symptom severity in some autistic groups compared with non-autistic comparison groups.
A 2025 study of more than 300 people added another interesting nuance. Autistic participants reported more bothersome psychological and somatic menopausal symptoms than non-autistic participants, but did not report higher vasomotor symptoms such as hot flushes.
That makes the picture much more interesting than simply saying autistic women “have worse menopause”.
The differences may be concentrated in particular kinds of symptoms and experiences.
ADHD and menopause may not be quite as straightforward as we thought either
There is increasing discussion of ADHD symptoms worsening during perimenopause, particularly around executive functioning, mood and sleep.
Recent reviews certainly support the idea that hormonal transitions may be relevant to ADHD symptoms and that female-specific treatment research is needed.
But a 2025 study comparing women with and without ADHD found something worth paying attention to: women with ADHD did not report greater menopausal complaints overall than women without ADHD at any menopausal stage. ADHD symptoms were correlated with menopause complaints across participants, but the group-level difference people might have expected was not there.
I actually think findings like this make the topic more credible rather than less.
Research is rarely neat.
It may be that certain women with ADHD experience very significant hormonal changes in symptoms while others do not. It may be that symptom overlap makes attribution difficult. Or there may be subgroups we have not yet properly identified.
What we should avoid is turning an emerging field into another universal story about what happens to every neurodivergent woman.
Sometimes perimenopause is when the whole picture finally becomes visible
There is something else happening here which may have less to do with hormones directly and more to do with life.
By the time somebody reaches her 40s, she may be holding a senior role, managing people, raising children, caring for parents, dealing with increasing financial responsibility and carrying decades of accumulated demands.
If she has spent her whole life compensating for undiagnosed ADHD or autism, that compensation takes energy.
Then sleep changes. Hormones fluctuate. Working memory becomes less reliable. Recovery takes longer.
And suddenly the system that has worked for years no longer has much margin left in it.
That can look like somebody has suddenly “developed ADHD” in perimenopause.
She has not.
It may simply be the first time her environment, hormones and available capacity have made the underlying pattern impossible to ignore.
For some women, that becomes the beginning of finally understanding themselves.
What does all of this mean at work?
This is where I think the hormones and neurodivergence conversation becomes particularly important.
Imagine an autistic woman who has spent years managing an open-plan office by masking her sensory discomfort. During perimenopause, sleep disruption and increased sensory sensitivity mean she can no longer sustain the same level of compensation.
Or a woman with ADHD who has built an extremely effective system of lists, reminders and over-preparation. During a period of hormonal change, concentration and working memory become less reliable and suddenly that system starts falling apart.
The wrong conclusion is that she has become less capable.
A much more useful question is whether something about the way she works needs to change.
That might mean quieter working space, more control over working location, written information after meetings, clearer priorities, flexibility around start times, more recovery after travel or fewer unnecessary interruptions.
None of those things makes somebody less ambitious. They may be exactly what allows her to keep doing the work she is good at.
Managers do not need to become experts in endocrinology or neuroscience
This is one of the risks whenever a new area of workplace health becomes more visible.
We start thinking managers need to know everything.
They do not.
A manager does not need to understand dopamine pathways, oestrogen receptors or autistic sensory processing in order to support someone well.
They need to know enough to avoid making assumptions, listen properly and ask useful questions.
What has changed?
How is this affecting your work?
What parts of the working environment are making things harder?
What would help?
Is there anything we could adjust temporarily and review?
That will usually get you much further than trying to diagnose somebody from a webinar.
And women should not have to prove which part is hormones and which part is neurodivergence
This is another thing I would love workplaces to get better at.
Sometimes people do not know.
Someone may be dealing with ADHD, poor sleep, perimenopause and an unmanageable workload at exactly the same time. She should not need to separate those perfectly before being allowed to ask for some flexibility.
The purpose of workplace support is not to conduct a differential diagnosis. It is to understand what is getting in the way of somebody doing their job and whether something reasonable could help.
That feels like a much more human place to start.
There is still an enormous amount we do not know
The research has moved forward quickly, but this remains a developing field.
The 2025 systematic review of ADHD and sex hormones found only eleven eligible studies, many of them small. A 2026 review of menstrual health and ADHD similarly concluded that the evidence is growing but that more rigorous and inclusive studies are needed.
Autism research has similar limitations. Samples are often small, disproportionately White and late-diagnosed, and much of what we understand about menopause still comes from qualitative studies and self-report.
We need better longitudinal research that follows neurodivergent people through puberty, menstrual cycles, pregnancy, postpartum and menopause rather than studying each life stage in isolation.
We also need far more diversity in who gets studied.
But limited evidence does not mean women's experiences should be dismissed until we have perfect answers.
It means we stay curious without pretending we know more than we do.
The bigger lesson is that brains and bodies were never separate
Perhaps that is the most useful thing emerging from all of this research.
For a long time, we have treated women's health, mental health and neurodivergence as separate topics.
A woman goes to one clinician for ADHD. Another for her menstrual health. Someone else for menopause.
At work, neurodiversity sits with DEI while menopause sits with Wellbeing and menstrual health appears during an awareness month.
But the person experiencing all of those things has one brain and one body.
Her sleep affects her attention. Her hormones may interact with cognition. Her sensory environment affects stress. Her working conditions affect how much capacity she has left to compensate.
Understanding those intersections is not about creating increasingly complicated labels. It is about seeing the whole person. And perhaps that is where the most useful progress will come from.
Want to bring this conversation into your organisation?
At See Her Thrive, we help organisations understand the intersection between women’s health, hormones and neurodivergence and what it can mean for people at work.
Our sessions explore ADHD, autism, the menstrual cycle, PMDD and menopause through an evidence-informed and practical lens, helping managers and teams understand why experiences can change across hormonal life stages and what genuinely supportive workplaces can do differently.
We do not teach managers to diagnose people or tell neurodivergent women to just be more resilient. The focus is on understanding the interaction between brains, bodies and working environments so organisations can create support that is practical, individual and human.
Get in touch to talk about bringing a Women, Hormones & Neurodivergence session to your organisation or take a look at our upcoming training and events.
You can also explore our articles on Autism in Women or browse the wider See Her Thrive Library.
References
Brady, M. J., Jenkins, C. A., Gamble-Turner, J. M., Moseley, R. L., Janse van Rensburg, M., & Matthews, R. J. (2024). “A perfect storm”: Autistic experiences of menopause and midlife. Autism, 28(6), 1405–1418. https://doi.org/10.1177/13623613241244548
de Jong, M., et al. (2023). Premenstrual adjustment of psychostimulant dosage in women with ADHD: A case series. Frontiers in Psychiatry.
https://pubmed.ncbi.nlm.nih.gov/36965073/
Groenman, A. P., Torenvliet, C., Radhoe, T. A., Agelink van Rentergem, J. A., & Geurts, H. M. (2022). Menstruation and menopause in autistic adults: Periods of importance? Autism, 26(6), 1563–1572. https://doi.org/10.1177/13623613211059721
Grant, A., Axbey, H., Holloway, W., Caemawr, S., Craine, M., Lim, H., Shaw, S. C. K., & Ellis, R. (2025). Autism and the menopause transition: A mixed-methods systematic review. Autism in Adulthood. Advance online publication. https://doi.org/10.1177/25739581251369452
Kooij, J. J. S., et al. (2025). Sex hormones and attention-deficit/hyperactivity disorder in females: A systematic review.
https://pubmed.ncbi.nlm.nih.gov/40251875/
Kooij, J. J. S., et al. (2025). Female-specific treatment considerations in attention-deficit/hyperactivity disorder across the lifespan.
https://pubmed.ncbi.nlm.nih.gov/41115846/
Kondo, C., et al. (2025). Association between premenstrual syndrome or premenstrual dysphoric disorder and neurodevelopmental traits.
https://pubmed.ncbi.nlm.nih.gov/40699321/
Skommer, J., et al. (2025). Autism, menstruation and mental health: A scoping review and a call to action.
https://pubmed.ncbi.nlm.nih.gov/40635787/
Steward, R., Crane, L., Roy, E. M., Remington, A., & Pellicano, E. (2018). “Life is much more difficult to manage during periods”: Autistic experiences of menstruation. Journal of Autism and Developmental Disorders, 48, 4287–4292. https://doi.org/10.1007/s10803-018-3664-0